US Stock MarketDetailed Quotes

DNTH Dianthus Therapeutics

Watchlist
  • 23.050
  • -1.520-6.19%
Close May 22 16:00 ET
676.51MMarket Cap-7842P/E (TTM)

Dianthus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(FY)Dec 31, 2021
Total revenue
83.61%874K
-55.96%2.83M
-61.11%457K
-21.23%924K
476K
334.76%6.42M
1.18M
1.17M
1.48M
Operating revenue
83.61%874K
-55.96%2.83M
-61.11%457K
-21.23%924K
--476K
334.76%6.42M
--1.18M
--1.17M
--1.48M
Cost of revenue
Gross profit
Operating expense
129.42%18.72M
41.19%51M
13.02%13.41M
76.97%16.68M
8.16M
148.06%36.12M
11.87M
9.43M
14.56M
Selling and administrative expenses
143.94%5.64M
169.30%18.16M
127.39%4.63M
294.88%8.72M
--2.31M
244.73%6.74M
--2.04M
--2.21M
--1.96M
-General and administrative expense
143.94%5.64M
169.30%18.16M
127.39%4.63M
294.88%8.72M
--2.31M
244.73%6.74M
--2.04M
--2.21M
--1.96M
Research and development costs
123.67%13.08M
11.78%32.84M
-10.68%8.78M
10.28%7.96M
--5.85M
133.06%29.38M
--9.83M
--7.22M
--12.61M
Operating profit
-132.25%-17.84M
-62.17%-48.17M
-21.16%-12.96M
-90.93%-15.76M
-7.68M
-127.00%-29.71M
-10.69M
-8.25M
-13.09M
Net non-operating interest income expense
596.70%4.22M
316.07%4.76M
281.88%2.44M
146.88%1.03M
606K
38,066.67%1.15M
640K
416K
3K
Non-operating interest income
596.70%4.22M
316.07%4.76M
281.88%2.44M
146.88%1.03M
--606K
38,066.67%1.15M
--640K
--416K
--3K
Other net income (expense)
-950.00%-126K
-272.62%-145K
19.05%-51K
-157.41%-31K
-12K
423.08%84K
-63K
54K
-26K
Gain on sale of security
-33.33%-12K
-162.50%-85K
-60.00%-32K
-128.57%-16K
---9K
623.08%136K
---20K
--56K
---26K
Other non- operating income (expenses)
-3,700.00%-114K
-15.38%-60K
55.81%-19K
-650.00%-15K
---3K
---52K
---43K
---2K
----
Income before tax
-93.93%-13.75M
-52.95%-43.56M
-4.42%-10.56M
-89.66%-14.76M
-7.09M
-117.22%-28.48M
-10.12M
-7.78M
-13.11M
Income tax
Net income
-93.93%-13.75M
-52.95%-43.56M
-4.42%-10.56M
-89.66%-14.76M
-7.09M
-117.22%-28.48M
-10.12M
-7.78M
-13.11M
Net income continuous Operations
-93.93%-13.75M
-52.95%-43.56M
-4.42%-10.56M
-89.66%-14.76M
---7.09M
-117.22%-28.48M
---10.12M
---7.78M
---13.11M
Minority interest income
Net income attributable to the parent company
-93.93%-13.75M
-52.95%-43.56M
-4.42%-10.56M
-89.66%-14.76M
-7.09M
-117.22%-28.48M
-10.12M
-7.78M
-13.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-93.93%-13.75M
-52.95%-43.56M
-4.42%-10.56M
-89.66%-14.76M
-7.09M
-117.22%-28.48M
-10.12M
-7.78M
-13.11M
Basic earnings per share
-12.87%-0.54
-339.70%-8.45
-4.42%-0.7129
-619.56%-3.78
-0.4784
-117.22%-1.9218
-0.6827
-0.5253
-0.8847
Diluted earnings per share
-12.87%-0.54
-339.70%-8.45
-4.42%-0.7129
-619.56%-3.78
-0.4784
-117.22%-1.9218
-0.6827
-0.5253
-0.8847
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(FY)Dec 31, 2021
Total revenue 83.61%874K-55.96%2.83M-61.11%457K-21.23%924K476K334.76%6.42M1.18M1.17M1.48M
Operating revenue 83.61%874K-55.96%2.83M-61.11%457K-21.23%924K--476K334.76%6.42M--1.18M--1.17M--1.48M
Cost of revenue
Gross profit
Operating expense 129.42%18.72M41.19%51M13.02%13.41M76.97%16.68M8.16M148.06%36.12M11.87M9.43M14.56M
Selling and administrative expenses 143.94%5.64M169.30%18.16M127.39%4.63M294.88%8.72M--2.31M244.73%6.74M--2.04M--2.21M--1.96M
-General and administrative expense 143.94%5.64M169.30%18.16M127.39%4.63M294.88%8.72M--2.31M244.73%6.74M--2.04M--2.21M--1.96M
Research and development costs 123.67%13.08M11.78%32.84M-10.68%8.78M10.28%7.96M--5.85M133.06%29.38M--9.83M--7.22M--12.61M
Operating profit -132.25%-17.84M-62.17%-48.17M-21.16%-12.96M-90.93%-15.76M-7.68M-127.00%-29.71M-10.69M-8.25M-13.09M
Net non-operating interest income expense 596.70%4.22M316.07%4.76M281.88%2.44M146.88%1.03M606K38,066.67%1.15M640K416K3K
Non-operating interest income 596.70%4.22M316.07%4.76M281.88%2.44M146.88%1.03M--606K38,066.67%1.15M--640K--416K--3K
Other net income (expense) -950.00%-126K-272.62%-145K19.05%-51K-157.41%-31K-12K423.08%84K-63K54K-26K
Gain on sale of security -33.33%-12K-162.50%-85K-60.00%-32K-128.57%-16K---9K623.08%136K---20K--56K---26K
Other non- operating income (expenses) -3,700.00%-114K-15.38%-60K55.81%-19K-650.00%-15K---3K---52K---43K---2K----
Income before tax -93.93%-13.75M-52.95%-43.56M-4.42%-10.56M-89.66%-14.76M-7.09M-117.22%-28.48M-10.12M-7.78M-13.11M
Income tax
Net income -93.93%-13.75M-52.95%-43.56M-4.42%-10.56M-89.66%-14.76M-7.09M-117.22%-28.48M-10.12M-7.78M-13.11M
Net income continuous Operations -93.93%-13.75M-52.95%-43.56M-4.42%-10.56M-89.66%-14.76M---7.09M-117.22%-28.48M---10.12M---7.78M---13.11M
Minority interest income
Net income attributable to the parent company -93.93%-13.75M-52.95%-43.56M-4.42%-10.56M-89.66%-14.76M-7.09M-117.22%-28.48M-10.12M-7.78M-13.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -93.93%-13.75M-52.95%-43.56M-4.42%-10.56M-89.66%-14.76M-7.09M-117.22%-28.48M-10.12M-7.78M-13.11M
Basic earnings per share -12.87%-0.54-339.70%-8.45-4.42%-0.7129-619.56%-3.78-0.4784-117.22%-1.9218-0.6827-0.5253-0.8847
Diluted earnings per share -12.87%-0.54-339.70%-8.45-4.42%-0.7129-619.56%-3.78-0.4784-117.22%-1.9218-0.6827-0.5253-0.8847
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg